First Time Loading...

LianBio
NASDAQ:LIAN

Watchlist Manager
LianBio Logo
LianBio
NASDAQ:LIAN
Watchlist
Price: 0.29 USD -3.01% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

LIAN's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

LianBio operates as a biopharmaceutical company. [ Read More ]

The intrinsic value of one LIAN stock under the Base Case scenario is 0.17 USD. Compared to the current market price of 0.29 USD, LianBio is Overvalued by 40%.

Key Points:
LIAN Intrinsic Value
Base Case
0.17 USD
Overvaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
LianBio

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling LIAN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
LianBio

Provide an overview of the primary business activities
of LianBio.

What unique competitive advantages
does LianBio hold over its rivals?

What risks and challenges
does LianBio face in the near future?

Has there been any significant insider trading activity
in LianBio recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for LianBio.

Provide P/S
for LianBio.

Provide P/E
for LianBio.

Provide P/OCF
for LianBio.

Provide P/FCFE
for LianBio.

Provide P/B
for LianBio.

Provide EV/S
for LianBio.

Provide EV/GP
for LianBio.

Provide EV/EBITDA
for LianBio.

Provide EV/EBIT
for LianBio.

Provide EV/OCF
for LianBio.

Provide EV/FCFF
for LianBio.

Provide EV/IC
for LianBio.

Show me price targets
for LianBio made by professional analysts.

What are the Revenue projections
for LianBio?

How accurate were the past Revenue estimates
for LianBio?

What are the Net Income projections
for LianBio?

How accurate were the past Net Income estimates
for LianBio?

What are the EPS projections
for LianBio?

How accurate were the past EPS estimates
for LianBio?

What are the EBIT projections
for LianBio?

How accurate were the past EBIT estimates
for LianBio?

Compare the revenue forecasts
for LianBio with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of LianBio and its key competitors using the latest financial data.

Compare historical revenue growth rates
of LianBio against its competitors.

Analyze the profit margins
(gross, operating, and net) of LianBio compared to its peers.

Compare the P/E ratios
of LianBio against its peers.

Discuss the investment returns and shareholder value creation
comparing LianBio with its peers.

Analyze the financial leverage
of LianBio compared to its main competitors.

Show all profitability ratios
for LianBio.

Provide ROE
for LianBio.

Provide ROA
for LianBio.

Provide ROIC
for LianBio.

Provide ROCE
for LianBio.

Provide Gross Margin
for LianBio.

Provide Operating Margin
for LianBio.

Provide Net Margin
for LianBio.

Provide FCF Margin
for LianBio.

Show all solvency ratios
for LianBio.

Provide D/E Ratio
for LianBio.

Provide D/A Ratio
for LianBio.

Provide Interest Coverage Ratio
for LianBio.

Provide Altman Z-Score Ratio
for LianBio.

Provide Quick Ratio
for LianBio.

Provide Current Ratio
for LianBio.

Provide Cash Ratio
for LianBio.

What is the historical Revenue growth
over the last 5 years for LianBio?

What is the historical Net Income growth
over the last 5 years for LianBio?

What is the current Free Cash Flow
of LianBio?

Financials

Balance Sheet Decomposition
LianBio

Current Assets 257.8m
Cash & Short-Term Investments 252.3m
Receivables 1.8m
Other Current Assets 3.7m
Non-Current Assets 5.1m
PP&E 5m
Other Non-Current Assets 100k
Current Liabilities 25.6m
Accounts Payable 6.2m
Accrued Liabilities 17.8m
Other Current Liabilities 1.6m
Non-Current Liabilities 35m
Other Non-Current Liabilities 35m
Efficiency

Earnings Waterfall
LianBio

Revenue
0 USD
Operating Expenses
-106.6m USD
Operating Income
-106.6m USD
Other Expenses
18.6m USD
Net Income
-88m USD

Free Cash Flow Analysis
LianBio

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

LIAN Profitability Score
Profitability Due Diligence

LianBio's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
Negative Net Income
41/100
Profitability
Score

LianBio's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

LIAN Solvency Score
Solvency Due Diligence

LianBio's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

LianBio's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LIAN Price Targets Summary
LianBio

Wall Street analysts forecast LIAN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LIAN is 3.98 USD with a low forecast of 3.03 USD and a high forecast of 5.04 USD.

Lowest
Price Target
3.03 USD
945% Upside
Average
Price Target
3.98 USD
1 272% Upside
Highest
Price Target
5.04 USD
1 638% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

LIAN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

LIAN Price
LianBio

1M 1M
-100%
6M 6M
-80%
1Y 1Y
-86%
3Y 3Y
-98%
5Y 5Y
-98%
10Y 10Y
-98%
Annual Price Range
0.29
52w Low
0.2857
52w High
666.7636
Price Metrics
Average Annual Return -64.7%
Standard Deviation of Annual Returns 14.18%
Max Drawdown -100%
Shares Statistics
Market Capitalization 449.6m USD
Shares Outstanding 1 550 415 089
Percentage of Shares Shorted 0.83%

LIAN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

LianBio Logo
LianBio

Country

United States of America

Industry

Biotechnology

Market Cap

449.6m USD

Dividend Yield

99.18%

Description

LianBio operates as a biopharmaceutical company. The company is headquartered in Princeton, New Jersey and currently employs 107 full-time employees. The company went IPO on 2021-10-28. The firm has established production lines for nine candidate products, including Mavacamten, TP-03, NBTXR3, Infigratinib, BBP-398, Omilancor, NX13, LYR210, Sisunatovir. The firm's products cover five different treatment areas, including cardiovascular, cancer, ophthalmology, inflammatory diseases and respiratory indications.

Contact

NEW JERSEY
Princeton
103 Carnegie Center Drive, Suite 309, Suite 215
+16094862308.0
https://www.lianbio.com/

IPO

2021-10-28

Employees

107

Officers

Founder & Executive Chairman
Mr. Konstantin Poukalov
Interim CEO & Director
Mr. Adam Leo Stone
Interim CFO, VP & Head of Global Finance
Ms. Ehong Gu
Senior VP & General Counsel
Ji Chen
Chief Business Officer
Ms. Brianne Jahn
Chief Scientific Advisor
Dr. Michael Humphries M.D.
Show More
Senior VP & Global Head of Development
Mr. Levvy Lv D. Eng
Show Less

See Also

Discover More
What is the Intrinsic Value of one LIAN stock?

The intrinsic value of one LIAN stock under the Base Case scenario is 0.17 USD.

Is LIAN stock undervalued or overvalued?

Compared to the current market price of 0.29 USD, LianBio is Overvalued by 40%.